Bionovo, Inc.
Records under this name other than the patents Bionovo, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 3 of 3 · Back to Bionovo, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,482,029 | Composition for treatment of menopause Term ended Term ended Aug 31, 2026 · USPTO record | Term ended | Term ended Aug 31, 2026 | USPTO record |
| US 9,446,086 | Composition for treatment of menopause Term ended Ended no later than Mar 29, 2026 · USPTO record | Term ended | Ended no later than Mar 29, 2026 | USPTO record |
| US 7,700,136 | Scutellaria barbata extract for the treatment of cancer Lapsed on the fee record Ended Apr 20, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 20, 2022 | USPTO record |